Home » Topics » Regulatory

Regulatory
RSS

Novo Nordisk's insulin degludec obtains first approval

Oct. 2, 2012

Dacogen gains approval in the E.U. for acute myeloid leukemia

Oct. 2, 2012

Suini approved in Japan for type 2 diabetes

Oct. 2, 2012

Plavix gets Japanese approval for additional indication

Oct. 2, 2012

FDA expands approval of Venofer to pediatric patients

Oct. 1, 2012

Dainippon Sumitomo Pharma obtains approval for Aimix combination tablets

Oct. 1, 2012

Seebri Breezhaler approved for COPD maintenance treatment in Japan

Oct. 1, 2012

FDA approves Bayer's Stivarga for treatment of metastatic colorectal cancer

Sep. 28, 2012

Regeneron's Eylea receives second U.S. approval

Sep. 27, 2012

FDA approves denosumab in new indication

Sep. 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.